Patents by Inventor Claudio Festuccia

Claudio Festuccia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF A CANCER
    Publication number: 20230088704
    Abstract: Use of ABTL0812 in the treatment of a cancer in a human patient, wherein the cancer treatment is related to chemotherapy, targeted therapy treatment, immunotherapy treatment or radiotherapy treatment.
    Type: Application
    Filed: February 10, 2021
    Publication date: March 23, 2023
    Applicant: ABILITY PHARMACEUTICALS S.L.
    Inventors: Héctor PÉREZ MONTOYO, Marc YESTE-VELASCO, Pau MUÑOZ GUARDIOLA, José Alberto ALFÓN CORIAT, Carles DOMÈNECH GARCIA, Guillermo YOLDI SALINAS, Jose Miguel LIZCANO DE LA VEGA, Miguel Francisco SEGURA GUINARD, Laia PARIS-CODERCH, Claudio FESTUCCIA
  • COMPOUNDS FOR TREATING BRAIN CANCER
    Publication number: 20230049350
    Abstract: There is provided a compound of formula I or a pharmacologically acceptable salt thereof: for use in the treatment of a brain cancer selected from a MGMT positive astrocytic brain tumour, a metastatic brain cancer and primary CNS lymphoma and a method of treating said brain cancers in a patient in need thereof comprising administering to the patient said compound of formula I or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: July 27, 2022
    Publication date: February 16, 2023
    Inventors: Thomas Jorg Mehrling, Claudio Festuccia
  • Method and Compositions for Treating Glioblastoma
    Publication number: 20220362275
    Abstract: A method of treating glioma is provided. A combination protocol as described herein includes radiotherapy, chemotherapy, and pharmacotherapy. Resection of the glioma is optionally included in the combination protocol. Pharmacotherapy is conducted with an oleandrin-containing composition. Treatment of glioblastoma is particularly contemplated.
    Type: Application
    Filed: June 2, 2022
    Publication date: November 17, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, PEIYING YANG, CLAUDIO FESTUCCIA, JOSE R MATOS
  • Compounds for treating brain cancer
    Patent number: 11419853
    Abstract: There is provided a compound of formula I or a pharmacologically acceptable salt thereof: for use in the treatment of a brain cancer selected from a MGMT positive astrocytic brain tumor, a metastatic brain cancer and primary CNS lymphoma and a method of treating said brain cancers in a patient in need thereof comprising administering to the patient said compound of formula I or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: August 23, 2022
    Assignee: Purdue Pharmaceutical Products L.P.
    Inventors: Thomas Mehrling, Claudio Festuccia
  • ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20220257698
    Abstract: The present invention relates to the cyclic peptides that are agonists of the angiotensin II type 2 receptor (hereinafter the AT2 receptor) useful in the treatment of different types of solid cancer, in particular brain, colon, lung and ovarian cancer. The invention further relates to pharmaceutical compositions containing them and uses thereof for the treatment of cancer.
    Type: Application
    Filed: August 3, 2020
    Publication date: August 18, 2022
    Inventors: Pawel Namsolleck, Anneke Kuipers, Louwe De Vries, Claudio Festuccia
  • Therapies for cancer
    Patent number: 11311552
    Abstract: The invention relates to 6-{4-[1-(Propan-2-yl)piperidin-4-yl]-1,4-diazepan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide, or a pharmaceutically acceptable salt thereof, for use in treatment of CNS cancers. The invention also relates to combination treatments with irradiation and/or a chemotherapeutic agent for use in the treatment of cancer.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: April 26, 2022
    Assignee: Proximagen, LLC
    Inventors: Peter Richardson, Jacqueline Mary Walling, Claudio Festuccia
  • NOVEL THERAPIES FOR CANCER
    Publication number: 20180078563
    Abstract: The invention relates to 6-{4-[1-(Propan-2-yl)piperidin-4-yl]-1,4-diazepan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide, or a pharmaceutically acceptable salt thereof, for use in treatment of CNS cancers.
    Type: Application
    Filed: April 1, 2016
    Publication date: March 22, 2018
    Applicant: PROXIMAGEN LIMITED
    Inventors: Peter RICHARDSON, Jacqueline Mary WALLING, Claudio FESTUCCIA
  • COMPOUNDS FOR TREATING BRAIN CANCER
    Publication number: 20170189382
    Abstract: There is provided a compound of formula I or a pharmacologically acceptable salt thereof: for use in the treatment of a brain cancer selected from a MGMT positive astrocytic brain tumor, a metastatic brain cancer and primary CNS lymphoma and a method of treating said brain cancers in a patient in need thereof comprising administering to the patient said compound of formula I or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 6, 2017
    Applicant: Purdue Phamaceutical Products L.P.
    Inventors: Thomas Mehrling, Claudio Festuccia